Bringing Artificial Intelligence to Biopharma

Apr 01, 2022PAO-04-22-R250-07

At another stop on Pharma's Almanac's the Road to 50 States campaign, Mike Fero, Founder and CEO of TeselaGen Biotechnology, talks to Nigel about the similarities between physics and biology and the informatic platforms TeselaGen offers to biotech companies.